SHC icon

Sotera Health

10.32 USD
-0.16
1.53%
At close Apr 21, 4:00 PM EDT
After hours
10.32
+0.00
0.00%
1 day
-1.53%
5 days
-3.73%
1 month
-13.28%
3 months
-22.46%
6 months
-33.93%
Year to date
-24.23%
1 year
-6.94%
5 years
-58.88%
10 years
-58.88%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe and other regions.

Employees: 3,000

0
Funds holding %
of 7,419 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

225% more call options, than puts

Call options by funds: $1.16M | Put options by funds: $356K

59% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 56

30% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 30

4% more funds holding

Funds holding: 207 [Q3] → 215 (+8) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 11 [Q3] → 11 (+0) [Q4]

0.13% less ownership

Funds ownership: 93.4% [Q3] → 93.27% (-0.13%) [Q4]

18% less capital invested

Capital invested by funds: $4.41B [Q3] → $3.61B (-$799M) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$12
16%
upside
Avg. target
$12
16%
upside
High target
$12
16%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Barclays
Luke Sergott
28% 1-year accuracy
16 / 57 met price target
16%upside
$12
Overweight
Maintained
10 Apr 2025

Financial journalist opinion

Based on 3 articles about SHC published over the past 30 days

Neutral
GlobeNewsWire
4 days ago
Sotera Health Announces First-Quarter 2025 Earnings Release Date
CLEVELAND, April 17, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced it will release its financial results for the first-quarter ended March 31, 2025 before the market opens on Thursday, May 1, 2025. Following the release, management will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss the Company's financial results and operating highlights.
Sotera Health Announces First-Quarter 2025 Earnings Release Date
Neutral
Zacks Investment Research
1 week ago
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Investors need to pay close attention to Sotera Health (SHC) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Sotera Health (SHC) Stock?
Positive
Seeking Alpha
1 week ago
Sotera Health Has A Great Deleveraging Path Ahead
Sotera Health offers essential sterilization, lab testing, and advisory services, ensuring safety and regulatory compliance for medical, pharmaceutical, and food products, with high customer retention and long-term contracts. The company operates through Sterigenics, Nordion, and Nelson Labs, with a global network and leading market positions in sterilization services and Co-60 supply. Despite a 6% revenue decline in FY24 due to Nordion's lumpy revenue, Sotera maintains high adjusted EBITDA margins (~50%) and plans for CapEx reduction and debt deleveraging.
Sotera Health Has A Great Deleveraging Path Ahead
Neutral
GlobeNewsWire
1 month ago
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results
Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application Rapid Sterility Testing yields product sterility test results in as little as 6 days and can be used for broadscale medical device and pharmaceutical product application
Nelson Labs Launches Innovative Rapid Sterility Testing to Significantly Expedite Product Sterility Results
Neutral
Seeking Alpha
1 month ago
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Sotera Health Company (NASDAQ:SHC ) Q4 2024 Earnings Conference Call February 27, 2025 9:00 AM ET Company Participants Jason Peterson – Vice President of Investor Relations and Treasurer Michael Petras – Chairman and Chief Executive Officer Jon Lyons – Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Sean Dodge – RBC Capital Markets Luke Sergott – Barclays Casey Woodring – J.P. Morgan Brett Fishbin – KeyBanc Dave Windley – Jefferies Michael Polark – Wolfe Research Operator Good morning, and welcome to the Sotera Health Fourth Quarter and Full Year 2024 Conference Call.
Sotera Health Company (SHC) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Sotera Health (SHC) Q4 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
1 month ago
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.21 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.26 per share a year ago.
Sotera Health Company (SHC) Meets Q4 Earnings Estimates
Neutral
GlobeNewsWire
1 month ago
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook
CLEVELAND, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2024 and its initial 2025 outlook.
Sotera Health Reports Fourth-Quarter and Full-Year 2024 Results; Provides 2025 Outlook
Neutral
Zacks Investment Research
1 month ago
Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics
Evaluate the expected performance of Sotera Health (SHC) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Insights Into Sotera Health (SHC) Q4: Wall Street Projections for Key Metrics
Neutral
GlobeNewsWire
2 months ago
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
CLEVELAND, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the fourth-quarter and full-year ended December 31, 2024 before the market opens on Thursday, February 27, 2025. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.
Sotera Health Announces Fourth-Quarter and Full-Year 2024 Earnings Release Date
Charts implemented using Lightweight Charts™